UnitedHealth Group Inc. (UNH) - Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. UnitedHealth Group operates two primary businesses: UnitedHealthcare (insurance) and Optum (health services). The filing reflects a business realignment effective January 1, 2026, moving Optum Financial (including Optum Bank) from Optum Health to Optum Insight. As of April 30, 2026, there were 908.1 million shares of common stock outstanding.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenues | $111,721 | $109,575 |
| Net Earnings (Attributable to UNH) | $6,280 | $6,292 |
| Diluted EPS | $6.90 | $6.85 |
| Operating Cash Flow | $8,912 | $5,456 |
| Medical Care Ratio (MCR) | 83.9% | 84.8% |
| Operating Margin | 8.0% | 8.3% |
| Total Assets | $312,644 | $309,581 |
| Cash & Cash Equivalents | $28,001 | $24,365 |
| Long-Term Debt | $71,440 | $72,320 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 2% year-over-year, driven by pricing trends at UnitedHealthcare and growth at Optum Rx, partially offset by a decline in people served.
- Membership Contraction: UnitedHealthcare served 1.1 million fewer people due to benefit design changes, reduced Medicaid eligibility, and Medicare Advantage funding pressures. Specifically, Medicare Advantage membership dropped 8% and Medicaid dropped 5%.
- Profitability: Earnings from operations decreased slightly to $8.99 billion from $9.12 billion. Net earnings attributable to shareholders were flat at approximately $6.28 billion.
- Cost Management: The Medical Care Ratio improved by 0.9 percentage points to 83.9%, aided by favorable reserve development and pricing, despite elevated medical cost trends. Operating costs rose 13% due to restructuring actions and investments in technology.
- Portfolio Actions: The company recorded a net gain of $230 million from portfolio divestitures, including gains at Optum Insight and Optum Rx, offset by losses at Optum Health.
Outlook, Risks, and Unusual Items
- Guidance & Trends: Management expects continued contraction in Medicare Advantage and Medicaid membership throughout 2026 due to funding pressures and eligibility reductions. Medical cost trends remain elevated due to provider pricing and care intensity.
- Legal & Regulatory:
- IRS Audit: Received Notices of Proposed Adjustment (NOPAs) for tax years 2017-2020 regarding intercompany transfer pricing. The company intends to contest these adjustments vigorously.
- DOJ Litigation: Ongoing False Claims Act lawsuit regarding risk adjustment submissions. A Special Master recommended summary judgment in the company's favor in March 2025, but the DOJ has moved to reject this report.
- Unusual Items:
- Restructuring: Included a $400 million contribution to the United Health Foundation funded by disposition proceeds.
- Dispositions: Completed sales of businesses held for sale for $1.1 billion, recording a net gain of $211 million.
- South America: Agreed to sell remaining South American operations, expected to close in H2 2026, with losses related to foreign currency translation.
- Capital Allocation: Entered into forward share repurchase contracts for up to $2.0 billion. Paid $2.0 billion in dividends ($2.21 per share).
Investor Verification Checklist
- Membership Trends: Verify the sustainability of the 1.1 million member decline and its impact on future premium revenue.
- Medicare Advantage Rates: Assess the impact of multi-year rate shortfalls and risk adjustment model revisions on future margins.
- IRS Dispute: Monitor the outcome of the IRS transfer pricing audit for potential tax liability impacts.
- Medical Cost Trends: Confirm if the favorable reserve development in Q1 is a one-time benefit or indicative of a longer-term trend.
- Divestiture Proceeds: Track the deployment of the $1.1 billion in cash received from dispositions and the $3.0 billion in pending acquisitions.